It is recognized for its Masimo SET Pulse Oximetry, a technology that significantly improves accuracy in measuring a patient's oxygen saturation and pulse even in the presence of motion.

Masimo (NASDAQ: MASI) today announced that its management will participate in the Jefferies London Healthcare Conference on Thursday, November 21, 2024 at 8:30 a.m. GMT. A live webcast of the ...

Some pulse oximeter manufacturers say their devices work accurately on all skin tones. A recent industry-funded study found ...

The other low-alarm-rate instrument (Masimo SET) identified both conditions equally or even more reliably than a conventional pulse oximeter.

Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Shares of Masimo Co. (NASDAQ:MASI – Get Free Report) have received an average rating of “Moderate Buy” from the seven ...

Apple and Masimo are back in a California court this week for a bench trial that will see Masimo arguing that Apple illegally ...

Offers optional dual IBP, and EtCo 2 — Now with Masimo SET ® Pulse Oximetry! The fully-functional Waveline Touch features a 12.1" color TFT display with a touch-screen interface. It features ...

This absorption prevents the light from penetrating through the tissue and blood to be accurately read by the pulse oximeter. 2 Medtronic Nellcor™ SpO2 device vs. Masimo SET™* SpO2 device In ...

A lawsuit against pulse oximeter manufacturers and distributors is starting to create change. But experts say the FDA needs ...

Apple won the case, though was only awarded a nominal $250, which is the smallest amount it was possible for the court to order. In other words, yes Masimo did in infringe Apple’s patents, but there ...

Masimo SET ® Measure-through Motion and Low Perfusion ... and Radius VSM™, portable devices like Rad-67 ®, fingertip pulse oximeters like MightySat ® Rx, and devices available for use ...